|
SIP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.324500E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.920610E-01 |
| Normal-vs-Stage2 |
8.460100E-03 |
| Normal-vs-Stage3 |
1.312240E-02 |
| Normal-vs-Stage4 |
5.099900E-02 |
| Stage1-vs-Stage2 |
5.678300E-02 |
| Stage1-vs-Stage3 |
6.876400E-02 |
| Stage1-vs-Stage4 |
2.254200E-01 |
| Stage2-vs-Stage3 |
8.968000E-01 |
| Stage2-vs-Stage4 |
6.412600E-01 |
| Stage3-vs-Stage4 |
5.817000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.058900E-03 |
| Normal-vs-AfricanAmerican |
6.012800E-01 |
| Normal-vs-Asian |
4.937600E-01 |
| Caucasian-vs-AfricanAmerican |
1.492320E-02 |
| Caucasian-vs-Asian |
1.376760E-01 |
| AfricanAmerican-vs-Asian |
6.618200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.149550E-02 |
| Normal-vs-Female |
4.455700E-02 |
| Male-vs-Female |
6.220800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.627980E-01 |
| Normal-vs-Age(41-60Yrs) |
1.393250E-01 |
| Normal-vs-Age(61-80Yrs) |
2.502500E-03 |
| Normal-vs-Age(81-100Yrs) |
2.258200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.854200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.047000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.950800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.624000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.762200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.299800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.993700E-02 |
| Normal-vs-Grade 2 |
1.047760E-01 |
| Normal-vs-Grade 3 |
1.267920E-02 |
| Normal-vs-Grade 4 |
1.168180E-02 |
| Grade 1-vs-Grade 2 |
1.153840E-02 |
| Grade 1-vs-Grade 3 |
1.135140E-03 |
| Grade 1-vs-Grade 4 |
6.203500E-04 |
| Grade 2-vs-Grade 3 |
1.657610E-01 |
| Grade 2-vs-Grade 4 |
9.130400E-02 |
| Grade 3-vs-Grade 4 |
5.432400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.067600E-01 |
| Normal-vs-ccB subtype |
1.118120E-02 |
| ccA subtype-vs-ccB subtype |
1.460970E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.350000E-02 |
| Normal-vs-N1 |
8.676300E-03 |
| N0-vs-N1 |
1.507190E-01 |
|
|
